Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study

Abstract

OBJECTIVE: We have previously shown that epithelial ovarian cancer (EOC) and its treatments have negative effects on long-term quality of life (QoL) and fatigue. The present multicenter study investigated the main menopausal symptoms and gynecological management of EOC survivors (EOCS). METHODS: 166 patients with relapse-free ≥3 years after the end of treatment attended a consultation with a gynecologist, including a questionnaire related to vasomotor symptoms (VMS) and sexuality, a clinical examination, a blood sample and an osteodensitometry. QoL, fatigue, insomnia and mood disorders were measured with validated questionnaires and correlated to VMS. VMS and QoL were assessed according to natural menopause (NM) or surgical menopause (SM). RESULTS: Mean age at the survey was 62 [21-83] years and stage III/IV (48%). Mean delay since the end of treatment was 6 years. Fifty-nine patients (36%) had SM. Half of patients reported VMS. Seventy-two percent of EOCS with SM had VMS compared to 41% with NM (P < .001). VMS were not associated with poor global QoL, fatigue, insomnia or mood disorders. Two-thirds of EOCS reported a decrease in libido. Patients with SM showed a greater decrease in libido than NM (P < .02). Fourteen percent of them had osteoporosis and 50% osteopenia. Among the 85 patients with VMS, 80 did not receive HRT after cancer treatment. At the time of the survey, only 7 (4%) patients were receiving hormone replacement therapy (HRT). CONCLUSIONS: VMS and sexual disorders are frequently reported by EOCS, particularly among patients with SM. Most EOCS with menopausal symptoms could benefit from HRT to improve these symptoms.

Efficacy and Safety of Vitex Extract on Menopausal Symptoms and Quality of Life in Postmenopausal Women: A Randomized Placebo-Controlled Trial
Prasanna A Reddy, Srilakshmi Aluri, Anzar CA +6
Cureus19 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
The Relationship Between Menopausal Symptoms and Life Satisfaction in Menopausal Women: The Mediating Role of Psychological Flexibility
Nefise Demir, Zuhal Koç Apaydın, Oğuz Çalıova +2
Current Research in Health Sciences1 Oct 2026Peer-reviewedCC BY-NCFull textEndocrinology & metabolismDOAJ
Menopausal symptoms, sexual function, and psychological well-being in women across the menopausal transition.
Katja Brenk-Franz, Mara Petersen, Bernhard Strauß
Comprehensive psychoneuroendocrinology17 Oct 2026Peer-reviewedCC BY-NC-NDFull textPsychiatry & mental healthEurope PMC
Efficacy and safety of non-hormonal pharmacotherapies for depressive and anxiety symptoms during the menopausal transition and postmenopause: a systematic review.
Mojtaba Hedayati Ch, Zahra Bostani Khalesi, Mahmood Abedinzade
BMC psychiatry1 Jul 2026Peer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismEurope PMCDOAJ
Social determinants of health and menopausal symptoms: the mediating role of menopausal attitudes
E Salış, E Kavlu, D Arslantaş +1
The European Journal of Public Health1 Oct 2026Peer-reviewedCC BY-NC 4.0Full textEndocrinology & metabolismPMCEurope PMC

Cite

BibTeX RIS

BibTeX

@article{gernier2026menopausal,
  title = {{Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study}},
  author = {F. Gernier and A. Gompel and C. Rousset-Jablonski and E. Kalbacher and A. Floquet and D. Berton-Rigaud and O. Tredan and J. Alexandre and P. Follana and A. Zannetti and N. Dohollou and J.-M. Grellard and B. Clarisse and I. Licaj and D. Ahmed-Lecheheb and R. Fauvet and P. Pautier and F. Joly},
  journal = {Gynecologic Oncology},
  year = {2026},
  month = sep,
  doi = {10.1016/j.ygyno.2021.10.001},
  url = {https://hal.science/hal-05741135v1},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study
AU  - F. Gernier
AU  - A. Gompel
AU  - C. Rousset-Jablonski
AU  - E. Kalbacher
AU  - A. Floquet
AU  - D. Berton-Rigaud
AU  - O. Tredan
AU  - J. Alexandre
AU  - P. Follana
AU  - A. Zannetti
AU  - N. Dohollou
AU  - J.-M. Grellard
AU  - B. Clarisse
AU  - I. Licaj
AU  - D. Ahmed-Lecheheb
AU  - R. Fauvet
AU  - P. Pautier
AU  - F. Joly
PY  - 2026
DA  - 2026/09/07
JO  - Gynecologic Oncology
DO  - 10.1016/j.ygyno.2021.10.001
UR  - https://hal.science/hal-05741135v1
AB  - OBJECTIVE: We have previously shown that epithelial ovarian cancer (EOC) and its treatments have negative effects on long-term quality of life (QoL) and fatigue. The present multicenter study investigated the main menopausal symptoms and gynecological management of EOC survivors (EOCS). METHODS: 166 patients with relapse-free ≥3 years after the end of treatment attended a consultation with a gynecologist, including a questionnaire related to vasomotor symptoms (VMS) and sexuality, a clinical examination, a blood sample and an osteodensitometry. QoL, fatigue, insomnia and mood disorders were measured with validated questionnaires and correlated to VMS. VMS and QoL were assessed according to natural menopause (NM) or surgical menopause (SM). RESULTS: Mean age at the survey was 62 [21-83] years and stage III/IV (48%). Mean delay since the end of treatment was 6 years. Fifty-nine patients (36%) had SM. Half of patients reported VMS. Seventy-two percent of EOCS with SM had VMS compared to 41% with NM (P < .001). VMS were not associated with poor global QoL, fatigue, insomnia or mood disorders. Two-thirds of EOCS reported a decrease in libido. Patients with SM showed a greater decrease in libido than NM (P < .02). Fourteen percent of them had osteoporosis and 50% osteopenia. Among the 85 patients with VMS, 80 did not receive HRT after cancer treatment. At the time of the survey, only 7 (4%) patients were receiving hormone replacement therapy (HRT). CONCLUSIONS: VMS and sexual disorders are frequently reported by EOCS, particularly among patients with SM. Most EOCS with menopausal symptoms could benefit from HRT to improve these symptoms.
SN  - 0090-8258
SN  - 1095-6859
ER  -

Abstract

Related

Cite